BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 1319314)

  • 1. Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
    Viviani MA
    Chemotherapy; 1992; 38 Suppl 1():35-42. PubMed ID: 1319314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mycoses as opportunistic infections in AIDS patients].
    Viviani MA
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():19-22. PubMed ID: 1663202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of candidiasis and cryptococcosis in AIDS].
    Just-NĂ¼bling G
    Mycoses; 1994; 37 Suppl 2():56-63. PubMed ID: 7609745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Itraconazole as maintenance treatment for cryptococcal meningitis in the acquired immune deficiency syndrome.
    de Gans J; Eeftinck Schattenkerk JK; van Ketel RJ
    Br Med J (Clin Res Ed); 1988 Jan; 296(6618):339. PubMed ID: 2830934
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itraconazole in opportunistic mycoses: cryptococcosis and aspergillosis.
    Denning DW; Tucker RM; Hanson LH; Stevens DA
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):602-7. PubMed ID: 2170480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histoplasmosis in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and fluconazole.
    Sharkey-Mathis PK; Velez J; Fetchick R; Graybill JR
    J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):809-19. PubMed ID: 8389850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral azole drugs as systemic antifungal therapy.
    Como JA; Dismukes WE
    N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azoles and AIDS.
    Larsen RA
    J Infect Dis; 1990 Sep; 162(3):727-30. PubMed ID: 2167339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Itraconazole therapy for cryptococcal meningitis and cryptococcosis.
    Denning DW; Tucker RM; Hanson LH; Hamilton JR; Stevens DA
    Arch Intern Med; 1989 Oct; 149(10):2301-8. PubMed ID: 2552949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Commonly used antifungal agents in the treatment of systemic mycoses].
    Berenguer Berenguer J
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral and parenteral treatment with itraconazole in various superficial and systemic experimental fungal infections. Comparisons with other antifungals and combination therapy.
    Van Cutsem J
    Br J Clin Pract Suppl; 1990 Sep; 71():32-40. PubMed ID: 1965417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs for treatment of fungal infections.
    Med Lett Drugs Ther; 1992 Feb; 34(864):14-6. PubMed ID: 1310518
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination therapy for systemic mycosis.
    Polak A
    Infection; 1989; 17(4):203-9. PubMed ID: 2548963
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of therapeutic activity of fluconazole and itraconazole in the treatment of oesophageal candidiasis in AIDS patients: a double-blind, randomized, controlled clinical study.
    Barbaro G; Di Lorenzo G
    Ital J Gastroenterol; 1995 May; 27(4):175-80. PubMed ID: 8520033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the treatment of systemic fungal infections.
    Walsh TJ
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
    Eloy O; Joly V; Ghnassia JC; Carbon C; Yeni P
    Presse Med; 1992 May; 21(20):937-42. PubMed ID: 1322537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. US experience with itraconazole in Aspergillus, Cryptococcus and Histoplasma infections in the immunocompromised host.
    Hostetler JS; Denning DW; Stevens DA
    Chemotherapy; 1992; 38 Suppl 1():12-22. PubMed ID: 1319310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The treatment of aspergillosis, cryptococcosis and histoplasmosis in immunocompromised patients. Report of experience in the United States].
    Hostetler JS; Stevens DA
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():8-10. PubMed ID: 1663205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of microsporidial epithelial keratopathy in a patient with AIDS.
    Yee RW; Tio FO; Martinez JA; Held KS; Shadduck JA; Didier ES
    Ophthalmology; 1991 Feb; 98(2):196-201. PubMed ID: 1848925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.